Donor screening

Ensuring access to a sufficient and safe supply of whole blood and plasma products is a challenge.¹ As a global leader and the single provider for a complete donor screening solution to blood centres and plasma fractionators worldwide*, Roche recognises this challenge and is committed to keeping the blood and plasma supply safe. To this end, we:

• Provide the most comprehensive donor screening solution
• Engage in active surveillance of emerging pathogens 
• Partner with leaders in the field of blood safety to develop innovative solutions
• Offer healthcare consulting to optimise each individual laboratory's solution
  

Partner with Roche, the only provider of a donor screening solution that integrates NAT, serology, lab automation and software solutions. Roche has been dedicated to blood screening since 1998 and leading blood screening centres globally choose to partner with us.¹  

Roche has a strong heritage in infectious diseases and the assays offered for blood screening exploit innovative technologies specifically developed for our serology and nucleic acid testing (NAT) platforms.

Laboratory automation and software solutions offered by Roche simplify, streamline and standardise the blood screening process. They support seamless connectivity and traceability at all levels of throughput, allowing reduction in errors, more consistent results, and ultimately more control over your laboratory's process.

By combining highly sensitive and specific NAT and state-of-the-art serology assays with fully integrated automation solutions, we provide scalable, powerful infectious disease screening configurations that grow with you.

From laboratory automation and software solutions to NAT and serology testing, complemented by healthcare consulting, Roche offers a comprehensive solution for whole blood and plasma screening.